Cargando…
Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery
[Image: see text] New, safe and effective drugs are urgently needed to treat and control malaria and tuberculosis, which affect millions of people annually. However, financial return on investment in the poor settings where these diseases are mostly prevalent is very minimal to support market-driven...
Autores principales: | Okombo, John, Chibale, Kelly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518282/ https://www.ncbi.nlm.nih.gov/pubmed/28636311 http://dx.doi.org/10.1021/acs.accounts.6b00631 |
Ejemplares similares
-
Correction: Recent updates in the discovery and development of novel antimalarial drug candidates
por: Okombo, John, et al.
Publicado: (2018) -
Plasmodium Kinases as Potential Drug
Targets for Malaria: Challenges and Opportunities
por: Arendse, Lauren B., et al.
Publicado: (2021) -
Target Identification in Anti-Tuberculosis Drug Discovery
por: Capela, Rita, et al.
Publicado: (2023) -
Strategies to Combat Multi-Drug Resistance in Tuberculosis
por: Singh, Vinayak, et al.
Publicado: (2021) -
Innovation
Experiences from Africa-Led Drug Discovery
at the Holistic Drug Discovery and Development (H3D) Centre
por: Singh, Vinayak, et al.
Publicado: (2022)